In vivo administration of low-dose human interleukin-2 induces lymphokine-activated killer cells for enhanced cytolysis in vitro

This publication has 9 references indexed in Scilit:

• Intradermal Recombinant Interleukin 2 Enhances Peripheral Blood T‐Cell Responses to Mitogen and Antigens in Patients with Lepromatous Leprosy
  Scandinavian Journal of Immunology, 1990
• Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors.
  The Journal of Experimental Medicine, 1990
• The generation of antigen-specific, major histocompatibility complex-restricted cytotoxic T lymphocytes of the CD4+ phenotype. Enhancement by the cutaneous administration of interleukin 2.
  The Journal of Experimental Medicine, 1989
• The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.
  The Journal of Experimental Medicine, 1989
• The recombinant 65-kD heat shock protein of Mycobacterium bovis Bacillus Calmette-Guerin/M. tuberculosis is a target molecule for CD4+ cytotoxic T lymphocytes that lyse human monocytes.
  The Journal of Experimental Medicine, 1988
• The nature and kinetics of a delayed immune response to purified protein derivative of tuberculin in the skin of lepromatous leprosy patients.
  The Journal of Experimental Medicine, 1988
• Local and Systemic Effects of Intradermal Recombinant Interferon-γ in Patients with Lepromatous Leprosy
  New England Journal of Medicine, 1986
• The cutaneous infiltrates of leprosy. A transmission electron microscopy study.
  The Journal of Experimental Medicine, 1983
• Specific antimononuclear phagocyte monoclonal antibodies. Application to the purification of dendritic cells and the tissue localization of macrophages.
  The Journal of Experimental Medicine, 1983